Hederacoside C ameliorates colitis via restoring impaired intestinal barrier through moderating S100A9/MAPK and neutrophil recruitment inactivation.

Authors:
Zha ZX; Lin Y; Wang KX; Zhang YL; Li D and 3 more

Journal:
Acta Pharmacol Sin

Publication Year: 2022

DOI:
10.1038/s41401-022-00933-3

PMCID:
PMC9214479

PMID:
35732707

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China (No. 82073912), Suzhou Science and Technology Plan Project (SYS2019032), and a project funded by Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025